Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy - Wikidata - wikimedia - TriplyDB

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

http://www.wikidata.org/entity/Q28379440

about

Common antiepileptic drugs in pregnancy in women with epilepsy Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child Common antiepileptic drugs in pregnancy in women with epilepsy The longer term outcome of children born to mothers with epilepsy A clinical study of 57 children with fetal anticonvulsant syndromes An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes Additional educational needs in children born to mothers with epilepsy Radial microbrain form of micrencephaly: possible association with carbamazepine Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Drugs for epilepsy have teratogenic risks.Using current evidence in selecting antiepileptic drugs for use during pregnancy.Update on new developments in the study of human teratogens.The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation.Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child.Laser light scan analysis of the "anticonvulsant face".Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.Anti-epileptic drugs in pregnancy: current safety and other issues.Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.Developmental neuropathology of environmental agents.Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain Cognitive outcomes of prenatal antiepileptic drug exposure.Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs.Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory.Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.Teratogenicity of Antiepileptic Drugs.Neurobehavioral consequences of prenatal antiepileptic drug exposure.Prenatal exposures associated with neurodevelopmental delay and disabilities.Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.Induction of the UDP-Glucuronosyltransferase 1A1 during the Perinatal Period Can Cause Neurodevelopmental Toxicity.Early cognitive development in children born to women with epilepsy: a prospective report.Teratogenic effects of carbamazepine on embryonic eye development in pregnant mice.Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.Mega-dose carbamazepine complicating third trimester of pregnancy.Newer anticonvulsants: lamotrigine, topiramate and gabapentin.Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.

P2860

Q24187306-AC849780-B7A6-49E7-BECF-1C7644ECBF7D Q24193032-8D89F853-C3C5-4D01-BBF2-356D8A6EF2A3 Q24246634-EFC4CB87-765D-41EC-8A20-7DB0368E40FA Q24671544-9629FBA5-338E-4A76-B809-59E0FA700D6E Q24681122-EC9022AD-2352-470F-9608-0B7416D43940 Q28081205-63BBF139-72F6-413F-A16C-94603EE435BE Q28345141-4E55034A-B2B8-47BC-BDDE-D695B7546DB8 Q28375387-4B3D71E0-6C39-4B29-815B-FC699E517EF9 Q30443028-03C75351-5427-4652-86E3-E4E30714887F Q33795580-69C951B7-FA06-4C73-81AA-8040AC94E739 Q33899323-7F93766E-353A-4C30-AA4D-398530C2AFF8 Q34123327-9981EF86-B531-40CA-A380-C7AE1E8004BF Q34349772-2A8C85DC-4629-4082-A8C1-82ACB49194BA Q34544208-2B683507-ECF6-4036-8469-09D2F00B0174 Q34580137-B55222AC-41D6-43AA-B4B7-002E6ACB1BC9 Q34823805-92336BB7-BDEE-449E-B6C8-C651BE469138 Q35095179-5E3A4D38-A6F4-4291-8793-0975176F19A9 Q35439268-96C04E9E-9913-4B0D-A985-D9D5AEEFF812 Q35639110-7C5D8CA8-5755-4C14-B57B-28D81CC82B04 Q35745262-379077B7-6BFD-4ACE-A332-E2863D38311E Q35762249-2932A369-86A7-4BB7-97AA-CDD0ED171B72 Q36254665-6A1B1812-EE75-4D22-87DF-F9E9033D6A2C Q37168123-4FD472C5-711B-42B9-B7BC-C886A68915D0 Q37309361-72466F32-680F-49F1-A662-D52C20205F42 Q37345777-7AA8AD18-8F9B-4929-AD81-00727AE86024 Q37623101-961FB7A2-46D5-42E4-82DF-C400FCAE8E27 Q37980247-7F9099C3-5C6A-4A4D-AC6B-A8AC5DC53B4C Q38077730-2AAC8E5B-74B2-4A62-A179-27262E4EBF49 Q38550879-96333141-FB2F-4324-84C4-560B49F4A584 Q41150465-431C35F3-F5D8-4585-B89C-C8E016EA56C7 Q42969569-60A30704-BC57-4F6A-B857-B0B45469AAA0 Q43247043-25DA5C5F-D963-4508-8EF1-08D1D497554B Q45975878-ED916B73-B5DD-4DE7-929B-6F32F4D74B21 Q46446655-B6C321AA-C9AA-4F7E-845E-B1FC9B84E7EC Q50799679-C822EACE-0662-4B71-A16E-6364BA770447 Q53946261-E0586AAC-7183-451F-A163-9808A4323F75

P2860

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

http://www.wikidata.org/entity/Q28379440

description

1996 nî lūn-bûn

@nan

1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@ast

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@en

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@nl

type

label

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@ast

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@en

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@nl

prefLabel

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@ast

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@en

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@nl

P1433

Q28379440-82D6D537-4A2F-4BED-AD24-B0D1C6CD6B29

P1476

Q28379440-E9C639A2-84C9-439A-BA49-139DBB010BEC

P2093

Q28379440-29A15043-E92F-4411-9009-18DB99B43354

Q28379440-E1EE0341-88AE-473F-A61C-A6CF421C940A

P2860

Q28379440-02161C3B-6C06-46B1-A79B-11B333EB9166

Q28379440-3B85AB5C-A3D8-481E-8775-7E6A4C019F0C

Q28379440-620E88D4-679B-4CE4-837C-D31B5E192F56

Q28379440-6762CDA3-372D-40A7-8887-A1DC8E482AC5

Q28379440-6AABAA64-164A-4105-B2B3-A917C594DD96

Q28379440-B9184795-533A-46B1-8C02-D984362CBDFE

Q28379440-D04F652A-2BE5-412C-A56E-074A05EF2A6A

Q28379440-DA4C7EFA-B884-460A-8333-0433C8F4B5F3

Q28379440-E8D72466-8787-4F1D-ABBC-3A4CEC50CD7B

Q28379440-ED5F4C4F-8DAF-421D-86A6-929C0B373117

P304

Q28379440-6FF603F1-065E-4C33-BFD8-14EC3982DE3F

P31

Q28379440-65FF36C8-9B31-4F97-A473-F2BB6EEACABC

P356

Q28379440-9A05BA8B-EBE0-4BA5-9345-5B8E3069376E

P407

Q28379440-EA3D6E0A-42ED-4AB2-A861-3043FD6564AA

P433

Q28379440-E81D7BAC-F876-4B77-B7BA-C365A8FDB2D8

P478

Q28379440-C52C0AA6-9CAD-4DD4-B508-AA31046182FC

P577

Q28379440-D3BB44EC-9C1B-44B7-8890-541DAF914D4A

P5875

Q28379440-6A9AA0B1-25FA-4CD2-8A5A-B85CE0DB544F

P698

Q28379440-EF17D439-BD24-40FC-BEC1-38710C7D344F

P921

Q28379440-59C8074F-548B-4B13-A4C8-54E024D717AC

P932

Q28379440-701F1E99-68D7-4CF9-8BBB-FF0D21668795

P356

P1433

Archives of Disease in Childhood

P1476

Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy

@en

P2093

A Ornoy

http://www.w3.org/2001/XMLSchema#string

E Cohen

http://www.w3.org/2001/XMLSchema#string

P2860

Prenatal prediction of risk of the fetal hydantoin syndrome.

Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies.

Anticonvulsant teratogenesis: I. A study design for newborn infants.

Maternal epilepsy and birth defects: a case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC).

Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.

Malformations in offspring of 305 epileptic women: a prospective study.

Pattern of malformations in the children of women treated with carbamazepine during pregnancy.

Outcomes of pregnancy associated with antiepileptic drugs.

The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted.

Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.

P304

517-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ADC.75.6.517

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1996-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14193559

http://www.w3.org/2001/XMLSchema#string

P698

9014606

http://www.w3.org/2001/XMLSchema#string

P921

P932

1511819

http://www.w3.org/2001/XMLSchema#string